All ProductsDisplaying Products by Catalog Number (2300 - 2399)
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800
Cat. No. | Product Name / Activity |
---|---|
2301 | T 0070907 |
Highly potent and selective covalent PPARγ antagonist | |
2302 | Sanguinarine chloride |
Inhibitor of protein phosphatase 2C (PP2C) | |
2303 | PNU 282987 |
Selective α7 nAChR agonist | |
2304 | Devazepide |
Selective, orally active CCK1 receptor antagonist | |
2307 | Leukotriene B4 |
BLT1/BLT2 receptor agonist and potent chemotactic factor | |
2308 | Tabimorelin hemifumarate |
Potent, orally active ghrelin receptor agonist | |
2309 | SR 142948 |
Highly potent NTS receptor antagonist | |
2310 | SR 49059 |
Selective, orally active vasopressin V1A receptor antagonist | |
2311 | L-168,049 |
Potent, orally active human glucagon receptor antagonist | |
2312 | DNQX disodium salt |
Selective non-NMDA iGluR antagonist; water-soluble salt of DNQX (Cat. No. 0189) | |
2313 | QX 314 chloride |
Na+ channel blocker | |
2316 | AMG 9810 |
Potent and selective TRPV1 competitive antagonist | |
2318 | Pravastatin sodium salt |
HMG-CoA reductase inhibitor | |
2324 | Necrostatin-1 |
RIP1 kinase inhibitor; inhibits necroptosis | |
2332 | (+)-Igmesine hydrochloride |
Selective σ1 ligand; antidepressant | |
2333 | JNJ 16259685 |
Highly potent, mGlu1-selective non-competitive antagonist | |
2337 | Trequinsin hydrochloride |
Highly potent PDE3 inhibitor | |
2338 | MK 571 |
Potent CysLT1 (LTD4) inverse agonist. Also MRP1 inhibitor | |
2339 | WEB 2086 |
Potent PAF receptor antagonist | |
2342 | 4-Methylhistamine dihydrochloride |
Selective, high affinity H4 agonist | |
2345 | ZK 200775 |
Competitive non-NMDA iGluR antagonist | |
2347 | Salubrinal |
Selective inhibitor of eIF2α dephosphorylation | |
2348 | Gavestinel |
Potent and selective NMDA antagonist; acts at the glycine site | |
2349 | Dihydro-β-erythroidine hydrobromide |
α4β2, muscle type and Torpedo nAChR antagonist | |
2372 | ABT 702 hydrochloride |
Adenosine kinase inhibitor; orally active | |
2373 | T 0901317 |
Potent liver X receptor (LXR) agonist; also CAR inverse agonist | |
2382 | EMD 386088 hydrochloride |
Potent 5-HT6 agonist | |
2383 | Bryostatin 1 |
Protein kinase C activator | |
2385 | AMN 082 dihydrochloride |
Selective mGlu7 agonist | |
2386 | Fenobam |
Potent and selective mGlu5 negative allosteric modulator (NAM) | |
2390 | LY 456236 hydrochloride |
Selective mGlu1 antagonist | |
2391 | Astressin 2B |
Selective CRF2 antagonist | |
2392 | JTE 013 |
S1P2 receptor antagonist | |
2394 | SDZ NKT 343 |
Highly selective human NK1 antagonist | |
2395 | Sertraline hydrochloride |
5-HT reuptake inhibitor | |
2397 | Eplerenone |
Selective mineralocorticoid receptor antagonist |